Can Vascular Supply Be Targeted in Cancer Treatment?
Yes, targeting the vascular supply has become a promising strategy in cancer therapy. Anti-angiogenic drugs, such as bevacizumab, work by inhibiting VEGF, thereby preventing the formation of new blood vessels. This can slow down tumor growth and reduce its ability to metastasize.
